Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Bloody Hell .... People are acting like we are awaiting promised drill results from a possible duster LOL ...... Several times Mandem has stated extremely pleased ..... we are on the cusp of significant News and all the star's must be aligned no room for error everything quadruple checked .. END
Excellent presentation 58 slides apologies if already posted :
https://www.linkedin.com/in/dongkyu-uh-49091b29/overlay/1635494273036/single-media-viewer/?profileId=ACoAAAYCWewBZtAEGcXTa7_j-MAm8MqcnMa5Eno
Click on PDF File
Don't get drawn in regarding posters but his comment has wound me up ..... Then I decide to have look at his profile / portfolio Hmmmmmmmm Enough said .... What a complete B End
well, I will defo put it om my watchlist for 2023 so thanks for that.
But right now I am done shuffling and tweaking various stocks and levels.
My speculatives are:
HE1 (drill in the next 6-12 weeks)
AVCT. 2 announcements, 1 in Jan and 1 in feb
MMAG presumably a christmas trading update will come in Jan
HARL is a new one added but looks to be pretty rock solid so I expect to add to that as the months go by.
(The rest are largely keep and forget)
So all the very best to anyone who tunes in here and thanks for the tips.
I am off to the Alps now for a christmas/new year break (hopefully not my limbs!)
yes they do have a version for Omicron :
https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2905
1. A method of identifying a residue and/or residue-component in a residue on a surface, comprising (i) in a first step, contacting the residue with at least three molecular probes selected from the group comprising antibodies, affimers, aptamers, lectins, carbohydrate binding modules and mixtures thereof; (ii) in a second step, detecting a positive response from one or more probes, the collective response from said at least three molecular probes providing information regarding the identity, and optionally quantity, of the residue and/or residue-component in the residue.
https://www.freepatentsonline.com/y2022/0373467.html
as pointed out on other thread clearly states phase 1B ?
https://www.withpower.com/trial/phase-1-sarcoma-6-2021-6f477
worth a read /// 22/09/22
https://dr.ntu.edu.sg/handle/10356/161863?mode=full
Avacta’s proprietary pre|CISIONTM targeted chemotherapy platform, releases active drug only in the tumour, thereby limiting systemic exposure and improving the overall safety and therapeutic potential of these powerful anti-cancer treatments.
https://www.news-medical.net/suppliers/Avacta-Life-Sciences-Ltd.aspx
GMCC Hi
perhaps you can help I'm sure launch diagnostics changed portal mentioning they were part of the Avacta Group ? now seems to have been removed ... I Know your good at finding changes any help ?
https://www.launchdiagnostics.com/about-us/
good find that man
https://www.medifind.com/doctors/ruth-plummer/333311206